Global Proctitis Market - Industry Trends and Forecast to 2029

Global Proctitis Market Analysis and Insights

Proctitis is an inflammatory disease. It develops in the lining of the rectum caused by trauma to the anorectal area. This condition develops due to anal sex or the insertion of objects or harmful substances. Severe bleeding, anemia, ulcers, and fistulas are the common symptoms of proctitis and there can be severe problems if left untreated.

• The proctitis treatment is supportive and aims to reduce the severity of the symptoms. Data Bridge Market Research analyses that the proctitis market will grow at a CAGR of 6.90% during the forecast period of 2022 to 2029.

Proctitis Market Dynamics

Drivers

• Inflammation

Surging incidence rate of inflammation in patients or inflammatory diseases as a result of anal sex is directly propelling the demand for effective medical treatment. Increasing transmission of sexually transmitted diseases can result in the development of proctitis and therefore, call for an effective and advanced treatment.       

• Increasing investment for healthcare infrastructure

Another significant factor influencing the market's growth rate is the rising healthcare expenditure, which helps in improving its infrastructure. Growth and expansion of healthcare industry especially in the developing economies would invite the use and application of new and advanced medial technologies, equipment and drugs. This will directly increase the demand for proctitis treatment.

• Research and development activities

Growing number of strategic collaboration between public and private market players is inducing growth in the number of research and development activities on daily basis. These research and development proficiencies are being conducted in novel drugs and medical technologies that will propel the demand for proctitis treatment.

Furthermore, unhealthy sexual habits or unsafe sexual intercourses, rising initiatives by public and private organizations to spread awareness and increasing cases of inflammatory bowel disease and ulcerative colitis are the factors that will expand the market growth rate. Other factors such as the increase in the demand for effective therapies, availability of cost-effective drugs and rising adoption rate for early diagnostic procedures will positively impact the market's growth rate.

Opportunities

Rise in the level of personal disposable income and growing awareness in the developing economies pertaining to the availability of treatment options will further create lucrative market growth opportunities. Rising medical tourism globally, the emergence of biosimilars, increasing involvement of key players in product development and high potential of growth in the untapped market will create enough market growth opportunities.  

Restraints/Challenges Global Proctitis Market

However, high costs associated with research and development proficiencies and lack of effective treatment which cut down the scope of innovative medication, will emerge as one of the biggest restraints for the market. Dearth of awareness and required infrastructural facilities in the underdeveloped and backward economies, stringent government regulations towards approval of biosimilars and unfavourable conditions arising due to COVID-19 outbreak will further derail the market growth rate. Slow rate of approval for drugs and inhibitors, unmet medical needs and increasing cases of patent expiry will also challenge the market growth rate. 

This proctitis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on proctitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Annually, ulcerative colitis affects approximately 250,000 to 500,000 individuals in the U.S. and this figure has remained constant in the past 5 years.

The proctitis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Proctitis Market

The treatment for proctitis in this pandemic phase has been challenging. Owing to the measures taken to minimize the risk of SARS-CoV-2 infection in the population, such as lockdown, curfew, and social distancing, the situation for high-risk patients has worsened. Due to coronavirus's medical and psycho-socioeconomic impact, there has been higher risk of adverse outcomes, especially in patients with ulcerative colitis.

Recent Development

• In June 2021, Pfizer Inc., intiated a phase III clinical trial to assess the efficacy, safety and pharmacokinetics (PK) of tofacitinib in pediatric patients.

Global Proctitis Market Scope

The proctitis market is segmented on the basis of types, treatment, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

• Ulcerative
• Gonorrheal
• Others

On the basis of types, the proctitis market is segmented into ulcerative, gonorrheal and others.

Treatment

• Medication
• Surgery
• Others

On the basis of treatment, the proctitis market is segmented into medications, surgery and others. The medication segment has been further categorized into anti-inflammatory drugs, antibiotics and antifungals, immunosuppressant, biologics, amino-salicylate and others.

Route of administration

• Oral
• Parenteral
• Others

On the basis of route of administration, the proctitis market is segmented into oral, parenteral and others.  

End Users

• Hospitals
• Specialty Clinics
• Others

On the basis of end user, the proctitis market is segmented into hospitals, specialty clinics and others.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Others

On the basis of distribution channel, the proctitis market has also been segmented into hospital pharmacy, retail pharmacy and others.

Pipeline Analysis

In June 2021, Takeda Pharmaceutical Company Limited started a phase III clinical trial to assess of Vedolizumab in Japanese patients with moderate to severe Ulcerative Colitis. AbbVie, Takeda Pharmaceuticals, Roche, Teva Pharmaceutical Industries Ltd., Johnson and Johnson, AstraZeneca, Shire Pharmaceuticals and others are the involved in the development of potential drugs for the improvement of treatment of pouchitis treatment.

Proctitis Market Regional Analysis/Insights

The proctitis market is analysed and market size insights and trends are provided by country, types, treatment, route of administration, end users and distribution channel as referenced above.

The countries covered in the proctitis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the proctitis market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players, well-developed healthcare infrastructure in this region, and an increase in proctitis and favorable reimbursement policies.

Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increase in the awareness about proctitis in developing countries and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Proctitis Market Share Analysis

The proctitis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to proctitis market.

Some of the major players operating in the proctitis market are AbbVie Inc., Merck & Co., Inc, Johnson & Johnson Services, Inc., Allergan, Almirall, S.A, Tolmar Pharmaceuticals, Inc., AstraZeneca, Sun Pharmaceuticals Industries Ltd., Teva Pharmaceutical Industries Ltd., Cipla Inc., Abbott, Takeda Pharmaceutical Company Limited, Bausch Health, Mylan N.V., Zydus Cadila., Sebela Pharmaceuticals, Inc., LUPIN., Novartis AG and Glenmark Pharmaceuticals Ltd., among others.

Research Methodology : Global Proctitis Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-proctitis-market

SKU-52483